Improving FDA postmarket adverse event reporting for medical devices

被引：0
|
作者：
Wunnava, Susmitha [1 ,2 ]
Miller, Timothy A. [2 ,3 ]
Bourgeois, Florence T. [2 ,3 ]
机构：
[1] Harvard Med Sch, Harvard Mit Ctr Regulatory Sci, Boston, MA 02115 USA
[2] Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA 02115 USA
[3] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA
来源：
BMJ EVIDENCE-BASED MEDICINE | 2023年 / 28卷 / 02期
关键词：
diagnosis; health care quality; access; and evaluation; policy; public health; therapeutics; DATABASE; UTILITY;
D O I：
10.1136/bmjebm-2021-111870
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：83 / 84
页数：2
相关论文
共 50 条
  • [1] FDA amends postmarket program for medical devices
    不详
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (01) : 24N - 24N
  • [2] GENDER DISPARITIES IN ADVERSE EVENT REPORTING FOR MEDICAL DEVICES
    Pierce, Hudson
    Ahsan, Muhammad
    Goel, Shokhi
    Asfaw, Tirsit
    Anger, Jennifer
    Chughtai, Bilal
    [J]. JOURNAL OF UROLOGY, 2020, 203 : E1256 - E1257
  • [3] Implementation of adverse event reporting for medical devices, India
    Shukla, Shatrunajay
    Gupta, Madhur
    Pandit, Sabitri
    Thomson, Milu
    Shivhare, Abhimanyu
    Kalaiselvan, Vivekanandan
    Singh, Gyanendra Nath
    [J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2020, 98 (03) : 206 - 211
  • [4] IN VIDEO, FDA URGES ADVERSE EVENT REPORTING
    Cima, Greg
    [J]. JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2021, 259 (03): : 223 - 223
  • [5] Security and Privacy Qualities of Medical Devices: An Analysis of FDA Postmarket Surveillance
    Kramer, Daniel B.
    Baker, Matthew
    Ransford, Benjamin
    Molina-Markham, Andres
    Stewart, Quinn
    Fu, Kevin
    Reynolds, Matthew R.
    [J]. PLOS ONE, 2012, 7 (07):
  • [6] Missing data in FDA adverse event reporting systems
    Smith, Sheila Weiss
    Gogolak, Victor V.
    Deshpande, Gaurav
    Chung, Stephanie
    Mehta, Shekhar H.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S72 - S72
  • [7] An evaluation of the FDA adverse event reporting system and the potential for reporting bias
    Monnot, Andrew D.
    Fung, Ernest S.
    Compoginis, Goli S.
    Towle, Kevin M.
    [J]. JOURNAL OF COSMETIC DERMATOLOGY, 2021, 20 (06) : 1849 - 1854
  • [8] Vedolizumab Adverse Events: Analysis of the FDA Adverse Event Reporting System
    Jow, Steven
    Hutfless, Susan
    [J]. INFLAMMATORY BOWEL DISEASES, 2017, 23 : S35 - S36
  • [9] Postmarket adverse event reporting rates: How well do they approximate incidence estimates
    Hammond, Isaac W.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S127 - S127
  • [10] Improving Adverse Event Reporting for Compounded Drugs
    Dohm, Julie
    Kim, Jenny
    Woodcock, Janet
    [J]. JAMA INTERNAL MEDICINE, 2019, 179 (11) : 1461 - 1462
12345